Quitting Caffeine for Better Glucose Metabolism
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Registration Number
- NCT01030796
- Brief Summary
This project is a pilot study of caffeine abstinence in coffee-drinkers who have type 2 diabetes. Evidence suggests that caffeine may impair the control of glucose levels, especially in those people who have type 2 diabetes. Eliminating caffeinated beverages from the diet might improve glucose control, but the difficulty of quitting is unknown. This pilot study will follow a small number of type 2 diabetic patients for three months after a brief intervention designed to help people quit caffeine. Data on success with maintaining abstinence and on changes in glucose control will be collected.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
- 6-month history of type 2 diabetes
- impaired chronic glucose control (HbA1c >= 7%)
- daily consumption of 250 mg caffeine or more in coffee, tea, and other caffeinated beverages
Exclusion Criteria
- use of exogenous insulin
- use of non-diabetes medications that impact glucose metabolism
- medical of psychiatric history that prevents participation or increases risk
- current pregnancy
- current participation in other clinical trials
- deemed unable to comply with the study protocol for other reasons
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Caffeine abstinence baseline, 2 weeks, 1, 2, and 3 months
- Secondary Outcome Measures
Name Time Method HbA1c Baseline, 3 months
Trial Locations
- Locations (1)
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
Duke University Medical Center🇺🇸Durham, North Carolina, United States